OKYO Pharma Limited (NASDAQ:OKYO) Short Interest Update

OKYO Pharma Limited (NASDAQ:OKYO) was the target of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 338,000 shares, a growth of 30.4% from the February 13th total of 259,200 shares. Based on an average daily volume of 150,800 shares, the days-to-cover ratio is currently 2.2 days. Approximately 1.4% of the shares of the company are sold short.

OKYO Pharma Price Performance

OKYO Pharma stock traded down $0.07 during midday trading on Tuesday, hitting $1.43. The company’s stock had a trading volume of 20,684 shares, compared to its average volume of 123,065. OKYO Pharma has a 1-year low of $0.81 and a 1-year high of $1.90. The company has a 50-day moving average price of $1.17 and a two-hundred day moving average price of $1.10.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of OKYO Pharma in a research report on Tuesday, February 18th.

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.